Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT04584801Completed

SLP Model Development in the Diagnosis of COPD Patients

Role: lead

NCT04255446Not Yet Recruiting

Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing

Role: lead

NCT03499938Completed

Structured Light Plethysmography in Obstructive Airways Disease

Role: collaborator

NCT03492359Not ApplicableCompleted

Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)

Role: collaborator

NCT02543333Completed

Validation of Structured Light Plethysmography: Asthma

Role: lead

NCT02626468Unknown

Validation of Structured Light Plethysmography - Health and Disease

Role: lead

NCT02598336Not ApplicableCompleted

Validation of Structured Light Plethysmography

Role: lead

NCT02881632Completed

Pneumacare SLP Validation in Infants and in Clinical Bronchiolitis

Role: collaborator

NCT02374554Not ApplicableUnknown

Thora-3Di™ Respiratory Rate Validation

Role: lead

All 9 trials loaded